Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Samer Kaba"'
Autor:
Sam E. Mansour, Daniel B. Roth, Daniel F. Kiernan, Samer Kaba, Nancy M. Holekamp, David A Eichenbaum, Erica Werts
Publikováno v:
The British Journal of Ophthalmology
BackgroundThe 0.2 µg/day fluocinolone acetonide (FAc) implant delivers continuous, low-dose, intravitreal corticosteroid for the treatment of diabetic macular oedema (DMO). This ongoing, 3-year, observational clinical trial provides long-term, ‘re
Autor:
Florian Ermini, Samer Kaba, Jan Potempa, Christina Griffin, Stephen S. Dominy, Malgorzata Benedyk, Debasish Raha, Agata Marczyk, Glenn D Walker, Casey C. Lynch, Mai Nguyen, Piotr Mydel, Annelie Hellvard, Eric C. Reynolds, Hatice Hasturk, Ursula Haditsch, Andrei Konradi, Maurice A. Curtis, Richard L.M. Faull, Leslie J. Holsinger, Mark I. Ryder, Karina Adamowicz, Mike Dragunow, Barbara Potempa, Shirin Arastu-Kapur, Alexander Lee
Publikováno v:
Science advances, vol 5, iss 1
Science Advances
Science Advances
Gingipains from Porphyromonas gingivalis drive Alzheimer’s pathology and can be blocked with small-molecule inhibitors.
Porphyromonas gingivalis, the keystone pathogen in chronic periodontitis, was identified in the brain of Alzheimer’s dise
Porphyromonas gingivalis, the keystone pathogen in chronic periodontitis, was identified in the brain of Alzheimer’s dise
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::883a50af9b4a731c268d542b0ea8cca6
https://ruj.uj.edu.pl/xmlui/handle/item/80007
https://ruj.uj.edu.pl/xmlui/handle/item/80007
Autor:
Douglas Jeffery, Kottil Rammohan, Mary Beth Wash, Timon Bogumil, Ben Thrower, Richard Sater, Stephen S. Kirzinger, Raul N. Mandler, Patricia K. Coyle, Kim Bigley, Francis Boateng, Peter Jakobs, Daniel D. Mikol, Barrie J. Hurwitz, Samer Kaba, Subramaniam Sriram, Barry G. W. Arnason, Douglas S. Goodin, Sharon G. Lynch
Publikováno v:
Clinical Therapeutics. 30:1102-1112
It is not known whether the currently available treatment regimen of interferon beta-1b (IFNbeta-1b) 250 microg provides the maximum benefit possible in the treatment of relapsing-remitting multiple sclerosis (RRMS), or whether higher doses of IFNbet
Publikováno v:
Archives of Physical Medicine and Rehabilitation. 97:e91
Publikováno v:
Archives of Neurology. 51:1115-1119
Objective: To attempt to identify the site of the lesion causing continuous facial myokymia (CFM) in multiple sclerosis (MS) through the use of magnetic resonance imaging (MRI). Design: A case series was employed. Setting: The Baird Multiple Sclerosi
Autor:
Samer Kaba, Lawrence Jacobs, Carleton C. Stewart, Frederick Munschauer, Zahra Ghorishi, Diane Cookfair, Steven J. Greenberg
Publikováno v:
Journal of Clinical Immunology. 13:113-118
Triple-antibody flow cytometry was used to search for distinctive populations of peripheral blood lymphocyte immunophenotypes in multiple sclerosis (MS). Using monoclonal antibodies to the cell surface markers CD3, CD4, and CD8, T cell subsets were q
Publikováno v:
Clinical neuropharmacology. 27(6)
The neurobehavioral and pathologic features of Parkinson disease dementia (PDD) are virtually identical to those of dementia with Lewy bodies (DLB), suggesting that they represent different phenotypes of the same underlying disease. Both are characte
Publikováno v:
Annals of neurology. 41(3)
We found 42 of 74 patients (57%) with isolated monosymptomatic optic neuritis to have 1 to 20 brain lesions, by magnetic resonance imaging (MRI). All of the brain lesions were clinically silent and had characteristics consistent with multiple scleros
Publikováno v:
Neurology. 41:15-15
We found 23 of 48 patients (48%) with isolated monosymptomatic optic neuritis (ON) to have 1 to several brain lesions by MRI. All the brain lesions were clinically silent and had characteristics consistent with multiple sclerosis (MS). During 4 years